SCHEMBL18601656

SCHEMBL18601656

[CH2]CCNCc1ccc(OCCCCCc2ccccc2)c(-c2ccoc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.40
BCHE P06276 5/20 0.38
SLC2A1 P11166 1/20 0.38
C5AR1 P21730 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
S1PR1 P21453 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
ROCK2 O75116 1/20 0.35
KCNH2 Q12809 1/20 0.35
ROCK1 Q13464 1/20 0.35
S1PR3 Q99500 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979478 0.85 S1PR3 (0.52) S1PR1S1PR3S1PR5
SCHEMBL15042608 0.84 S1PR1 (0.38) SIGMAR1BCHESLC2A1CNR1CNR2
SCHEMBL18601658 0.84 SIGMAR1 (0.41) SIGMAR1BCHESLC2A1CNR1CNR2
SCHEMBL18601653 0.82 HTR1A (0.45) SIGMAR1BCHESLC2A1C5AR1CNR1
SCHEMBL18601657 0.81 BCHE (0.40) SIGMAR1BCHESLC2A1CNR1CNR2
SCHEMBL12760665 0.80 PLAU (0.38) SIGMAR1BCHES1PR1ALDH1A1CYP3A4
SCHEMBL18601662 0.79 SIGMAR1 (0.40) SIGMAR1BCHESLC2A1C5AR1CNR1
SCHEMBL1980086 0.78 S1PR1 (0.40) C5AR1S1PR1ALDH1A1CYP2C9S1PR3
SCHEMBL18601654 0.77 HTR1A (0.45) SIGMAR1BCHESLC2A1
SCHEMBL18601666 0.77 SLC6A9 (0.39) SIGMAR1BCHESLC2A1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504323-B1 NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY ALLERGAN INC (US) 2017-03-15 EP claimed